Ro CEO Zach Reitano joins ‘Mornings with Maria’ to discuss the launch of the Wegovy oral pill, the future of telehealth and ...

Health Canada approved last month two  brand names for generic semaglutide products, Plosbrio  and  Poviztra, which contain ...

Friendly” labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...

US FDA review finds no evidence linking GLP-1 receptor agonists in popular medicines like Wegovy and Zepbound to an increased ...

Novo Nordisk's new chief executive, Mike Doustdar, has told the JPM Healthcare conference that the key to competing in the GLP-1 agonist category for weight loss will be to make the most of cash-pay ...

After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, ...

The panel will host a Question and Answer session exploring the science behind the stories, and looking at whether the jabs ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

Novo Nordisk (NYSE: NVO) was once the top player in the weight loss drug market. The company's medicine, Wegovy, practically ...

Tucker Carlson's gaunt appearance sparks Ozempic rumours as weight-loss drugs become mainstream. Explore the latest ...